← FDA Drug Approvals (Drugs@FDA)

RIVFLOZA

NDA · New Drug Application · Sponsor: NOVO · Approved 2023-09-29

Drug application

FDA Application #

NDA215842

Application type

New Drug Application

Brand name

RIVFLOZA

Generic name

NEDOSIRAN

Active ingredients

NEDOSIRAN SODIUM

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

NOVO

Manufacturer

Novo Nordisk

First approval

2023-09-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown